Teva- Pharmaceutical Industries Overview
Teva- Pharmaceutical Industries Target Price
Analysts' average 12-month price target for Teva- Pharmaceutical Industries is $42.
Get informed when a big investor buys or sells
+ FollowShare Price
$35.01
Average Target Price
$42.00
20% upside
20% upside4 analysts in the last 4 months
High: $44 | Low: $40
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-28 | Piper SandlerDavid Amsellem | $44 | 25.7% upside |  |
| 2026-05-06 | Barclays | $40 | 14.3% upside | |
| 2026-04-30 | Piper Sandler | $42 | 20% upside | |
| 2026-04-30 | UBS | $42 | 20% upside | |
| 2026-03-04 | Piper SandlerDavid Amsellem | $41 | 17.1% upside | |
| 2026-01-30 | BarclaysGlen Santangelo | $38 | 8.5% upside | |
| 2026-01-29 | Scotiabank | $40 | 14.3% upside | |
| 2026-01-07 | Truist Financial | $36 | 2.8% upside | |
| 2026-01-06 | Jefferies | $40 | 14.3% upside | |
| 2025-12-22 | Piper Sandler | $40 | 14.3% upside | |
| 2025-12-18 | Goldman Sachs | $35 | 0% upside | |
| 2025-12-08 | Barclays | $35 | 0% upside | |
| 2025-12-04 | Scotiabank | $35 | 0% upside | |
| 2025-11-06 | Goldman SachsMatt Dellatorre | $28 |  20% downside | |
| 2024-12-18 | UBSAshwani Verma | $28 | 20% downside | |
| 2024-12-18 | BarclaysBalaji Prasad | $28 | 20% downside | |
| 2024-10-23 | BarclaysBalaji Prasad | $25 | 28.6% downside | |
| 2024-10-01 | Bank of America SecuritiesJason Gerberry | $22 | 37.2% downside | |
| 2024-09-03 | UBSAshwani Verma | $26 | 25.7% downside | |
| 2024-08-28 | Piper SandlerDavid Amsellem | $23 | 34.3% downside | |
| 2024-08-01 | BarclaysBalaji Prasad | $22 | 37.2% downside | |
| 2024-07-10 | Argus ResearchJasper Hellweg | $20 | 42.9% downside | |
| 2024-07-10 | UBSAshwani Verma | $24 | 31.4% downside | |
| 2024-06-05 | BarclaysBalaji Prasad | $21 | 40% downside | |
| 2024-05-23 | BarclaysBalaji Prasad | $20 | 42.9% downside | |
| 2024-05-13 | Piper SandlerDavid Amsellem | $20 | 42.9% downside | |
| 2024-02-12 | Piper SandlerDavid Amsellem | $19 | 45.7% downside | |
| 2024-01-23 | JefferiesGlen Santangelo | $14 | 60% downside | |
| 2022-11-14 | J.P. Morgan | $10 | 71.4% downside | |
| 2022-06-13 | UBSAshwani Verma | $10 | 71.4% downside | |
| 2022-05-04 | Piper Sandler | $7 | 80% downside | |
| 2022-04-20 | BarclaysBalaji Prasad | $13 | 62.9% downside | |